|Last Price$41.46||Day Change (%)1.47%|
|Open Price$40.85||Day Change ($)0.60|
|Day Range40.67–41.51||52-Week Range35.65–44.20|
As of Mon 10/20/2014 03:40 PM EST | USD
Abbott Laboratories ABT Announces Acquisition of CFR Pharmaceuticals
AbbVie formally scuttles deal to buy Shire
A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.
Simple formulas for foreign exposure lose luster.
AbbVie Board Recommends Stockholders Vote Against Shire Transaction
Research and Markets: Global Partial Seizure Clinical Trials Review, H2, 2014
Abbott Labs ABT had a strong showing at the American College of Cardiology's annual meeting this weekend, but the news was less positive for Boston Scientific BSX and partner Angiotech ANPI. Abbott revealed data from a head-to-head trial that demonstrated its Xience V drug-eluting stent performed ...
Research and Markets: Global Low-Calorie Food Market Outlook 2019 - Key Analysis of the $7.4 Billion Industry
Research and Markets: Global Biological Drugs Market Outlook 2020